Ebv-related Carcinoma

• CLINICAL_TRIALS trial_result · 2020-02-17
  Clinical Trial Update: Denosumab In Ebv Nasopharyngeal Carcinoma As A Model For RankMediated Immunologic Modulation Of Virus-Related Tumours [Phase 2]

  Phase 2 clinical trial evaluating denosumab as a model for rank-mediated immunologic modulation in virus-related nasopharyngeal carcinoma (E…

• CLINICAL_TRIALS trial_result · 2017-10-20
  Clinical Trial Update: Long-term Treatment Outcome for Stage III NPC Patients and Risk Grouping by Plasma EBV DNA

  This completed clinical trial reports long-term treatment outcomes for stage III nasopharyngeal carcinoma patients and evaluates risk groupi…